Progress in biological markers for Alzheimer's disease and mild cognitive impairment / 中华老年医学杂志

ABSTRACT

With the aggravation of aging of the population,the incidence of Alzheimer's disease (AD)has been steadily increasing,mild cognitive impairment (MCI)is considered as a cognitive state between aging and dementia.However,the diagnosis of AD and MCI is difficult and mainly depends on the clinical symptoms and the corresponding assessment scales,lacking of the application of biological markers.In this paper,we presented a general review of the biological markers related to AD and MCI,so as to provide reference for their clinical use.